Header Logo

Rosemary Zuna

Concepts (386)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
58
2022
297
6.920
Why?
Papillomavirus Infections
34
2022
143
4.510
Why?
Cervical Intraepithelial Neoplasia
32
2022
82
4.450
Why?
Papillomaviridae
32
2022
87
2.650
Why?
Human papillomavirus 16
12
2020
24
1.340
Why?
DNA, Viral
12
2020
56
1.290
Why?
Colposcopy
19
2021
61
1.200
Why?
Cervix Uteri
16
2020
65
1.190
Why?
Adenocarcinoma
6
2019
298
1.160
Why?
Precancerous Conditions
9
2020
37
1.130
Why?
Papanicolaou Test
7
2018
24
1.010
Why?
Vaginal Smears
15
2021
44
1.000
Why?
Uterine Cervical Dysplasia
7
2016
35
0.940
Why?
Female
88
2022
15153
0.940
Why?
Cytodiagnosis
4
2021
12
0.910
Why?
Genotype
18
2020
456
0.820
Why?
Carcinoma, Squamous Cell
9
2022
163
0.810
Why?
Adult
50
2021
7739
0.740
Why?
Middle Aged
41
2022
7137
0.720
Why?
Humans
93
2022
28094
0.720
Why?
Sensitivity and Specificity
14
2019
521
0.640
Why?
Carcinoma, Papillary
2
2015
18
0.630
Why?
Early Detection of Cancer
10
2022
126
0.610
Why?
Biomarkers, Tumor
10
2021
404
0.600
Why?
Aged
32
2020
5400
0.570
Why?
Biopsy
11
2018
206
0.560
Why?
Genotyping Techniques
4
2019
21
0.550
Why?
Fallopian Tubes
2
2016
15
0.540
Why?
Mutation
4
2020
845
0.540
Why?
Endometrium
2
2016
39
0.540
Why?
Kidney Neoplasms
2
2015
101
0.540
Why?
Image Interpretation, Computer-Assisted
2
2015
107
0.510
Why?
Tumor Virus Infections
5
2006
14
0.500
Why?
Proto-Oncogene Proteins c-met
1
2015
12
0.500
Why?
Endometrial Neoplasms
5
2013
189
0.490
Why?
Genetic Variation
5
2020
242
0.480
Why?
Young Adult
18
2020
2732
0.480
Why?
Ovarian Neoplasms
8
2019
589
0.470
Why?
NF-E2-Related Factor 2
1
2015
122
0.450
Why?
Adolescent
19
2020
3121
0.430
Why?
Subtraction Technique
1
2013
8
0.430
Why?
Pattern Recognition, Automated
1
2013
32
0.420
Why?
Microscopy
1
2013
38
0.420
Why?
Alphapapillomavirus
2
2017
8
0.410
Why?
Repressor Proteins
2
2011
118
0.390
Why?
Algorithms
2
2015
430
0.370
Why?
Aged, 80 and over
14
2019
2021
0.370
Why?
Uterine Neoplasms
4
2017
71
0.360
Why?
Oncogene Proteins, Viral
2
2014
16
0.360
Why?
High-Throughput Nucleotide Sequencing
3
2019
109
0.340
Why?
Genome, Viral
5
2020
31
0.320
Why?
Ovarian Cysts
3
2019
6
0.320
Why?
DNA Methylation
5
2018
152
0.310
Why?
Polymerase Chain Reaction
7
2015
269
0.290
Why?
Genital Neoplasms, Female
2
2018
67
0.260
Why?
Neoplasm Invasiveness
3
2016
190
0.260
Why?
Carcinosarcoma
2
2017
22
0.240
Why?
Papillomavirus Vaccines
3
2022
56
0.240
Why?
Peritoneal Lavage
3
1990
3
0.240
Why?
Gene Expression Regulation, Neoplastic
3
2018
465
0.220
Why?
Neoplasm Grading
5
2017
104
0.210
Why?
Reproducibility of Results
5
2014
769
0.210
Why?
Specimen Handling
4
2015
33
0.210
Why?
Risk Assessment
3
2020
612
0.200
Why?
Leiomyosarcoma
2
2022
10
0.200
Why?
Disease Progression
8
2015
473
0.200
Why?
Cell Nucleus
2
2015
138
0.190
Why?
Carcinoma in Situ
2
2001
46
0.190
Why?
Retrospective Studies
6
2018
2546
0.190
Why?
Neoplasm Staging
5
2016
478
0.180
Why?
Immunohistochemistry
5
2016
463
0.180
Why?
DNA Copy Number Variations
2
2018
36
0.180
Why?
Prognosis
6
2018
802
0.180
Why?
Quality Assurance, Health Care
1
2001
62
0.170
Why?
Molecular Diagnostic Techniques
2
2012
21
0.170
Why?
Granulosa Cell Tumor
2
2019
3
0.170
Why?
United States
5
2022
2146
0.170
Why?
Signal Transduction
3
2015
1435
0.170
Why?
Cytidine Deaminase
1
2020
8
0.170
Why?
Risk Factors
7
2013
2081
0.170
Why?
Neoplasms, Unknown Primary
1
1999
8
0.170
Why?
Research
1
2020
92
0.160
Why?
Cystadenocarcinoma, Serous
1
1999
32
0.160
Why?
CpG Islands
2
2017
26
0.160
Why?
Hysterectomy
2
2016
85
0.160
Why?
Pituitary Neoplasms
1
2019
48
0.160
Why?
Adenoma
1
2019
61
0.150
Why?
Genital Diseases, Female
2
1989
7
0.150
Why?
Carcinoma
2
2017
74
0.150
Why?
Drug Resistance, Neoplasm
2
2017
167
0.150
Why?
Oligonucleotide Array Sequence Analysis
2
2017
194
0.150
Why?
Phylogeny
5
2020
479
0.150
Why?
Metabolic Networks and Pathways
1
2018
49
0.150
Why?
Curettage
1
2017
4
0.140
Why?
Human papillomavirus 18
3
2019
6
0.140
Why?
Gene Regulatory Networks
1
2018
77
0.140
Why?
African Americans
1
2020
352
0.140
Why?
Celecoxib
1
2017
10
0.140
Why?
Mitochondrial Membrane Transport Proteins
1
2017
23
0.140
Why?
Pseudomyxoma Peritonei
1
1997
2
0.140
Why?
Struma Ovarii
1
1997
1
0.140
Why?
Calcium-Binding Proteins
1
2017
62
0.140
Why?
Viral Load
2
2019
31
0.140
Why?
Phenotype
2
2017
680
0.130
Why?
Glycolysis
1
2017
85
0.130
Why?
Salpingectomy
1
2016
8
0.130
Why?
Peritoneum
1
1996
8
0.130
Why?
Cation Transport Proteins
1
2017
60
0.130
Why?
Mucous Membrane
1
2016
28
0.130
Why?
Thyroid Neoplasms
1
1997
39
0.130
Why?
Ovariectomy
1
2016
53
0.130
Why?
Lymph Node Excision
1
2016
100
0.130
Why?
Peritoneal Neoplasms
1
1997
79
0.130
Why?
Virus Integration
1
2015
2
0.130
Why?
Intramolecular Oxidoreductases
1
2015
8
0.130
Why?
Macrophage Migration-Inhibitory Factors
1
2015
8
0.130
Why?
HLA-A2 Antigen
1
2015
18
0.130
Why?
Paraffin Embedding
1
2015
14
0.130
Why?
Adenocarcinoma, Mucinous
1
1995
10
0.130
Why?
Vascular Endothelial Growth Factor A
1
2017
179
0.130
Why?
RNA, Messenger
2
2015
659
0.120
Why?
RNA, Neoplasm
1
2015
24
0.120
Why?
DNA, Neoplasm
3
2009
34
0.120
Why?
Sequence Analysis, RNA
1
2015
58
0.120
Why?
Estrogen Receptor alpha
1
2015
27
0.120
Why?
Cross-Sectional Studies
5
2019
961
0.120
Why?
Stromal Cells
1
2015
61
0.120
Why?
Breast Neoplasms
2
2018
459
0.120
Why?
Polymorphism, Single Nucleotide
2
2017
547
0.120
Why?
Mixed Tumor, Mullerian
1
2014
1
0.110
Why?
Receptors, Vascular Endothelial Growth Factor
1
2014
8
0.110
Why?
Intestinal Mucosa
1
1995
197
0.110
Why?
Vulva
1
2013
5
0.110
Why?
Urine
1
2013
14
0.110
Why?
Microtomy
1
2013
2
0.110
Why?
Cell Line, Tumor
5
2018
1319
0.110
Why?
Gene Expression Profiling
3
2018
453
0.110
Why?
Follow-Up Studies
4
2013
1013
0.110
Why?
Chemoradiotherapy
1
2013
44
0.110
Why?
Polyploidy
1
2013
12
0.110
Why?
Sulfonamides
1
2014
73
0.110
Why?
Peptides
1
2015
288
0.110
Why?
Brachytherapy
1
2013
51
0.100
Why?
Transcription Factors
2
2013
520
0.100
Why?
Endonucleases
1
2013
17
0.100
Why?
Neoplasms
3
2013
808
0.100
Why?
Image Enhancement
1
2013
58
0.100
Why?
Angiogenesis Inhibitors
1
2014
109
0.100
Why?
Pyrimidines
1
2014
125
0.100
Why?
Neoplasm Recurrence, Local
2
2014
330
0.100
Why?
Oklahoma
5
2012
1007
0.100
Why?
Treatment Outcome
2
2016
2377
0.100
Why?
Sterilization, Tubal
1
2012
6
0.100
Why?
Neoplasms, Squamous Cell
1
2012
5
0.100
Why?
Mass Screening
4
2016
152
0.100
Why?
Neoplasms, Glandular and Epithelial
1
2013
72
0.100
Why?
Ki-67 Antigen
1
2012
23
0.100
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2012
16
0.100
Why?
Laser Capture Microdissection
3
2020
9
0.100
Why?
Apoptosis
2
2017
775
0.100
Why?
Genetic Heterogeneity
1
2012
31
0.100
Why?
Triage
2
2016
33
0.090
Why?
MicroRNAs
1
2015
301
0.090
Why?
Predictive Value of Tests
3
2001
474
0.090
Why?
Condylomata Acuminata
3
1987
4
0.090
Why?
Trophoblastic Neoplasms
1
1990
2
0.090
Why?
Choriocarcinoma
1
1990
6
0.090
Why?
Neovascularization, Pathologic
1
2011
149
0.090
Why?
Age Factors
3
2009
734
0.090
Why?
Adaptor Proteins, Signal Transducing
1
2011
163
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2011
328
0.080
Why?
Genes, Viral
2
2009
10
0.080
Why?
Biomarkers
1
2013
765
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2013
409
0.080
Why?
Prospective Studies
4
2018
1248
0.080
Why?
DNA-Binding Proteins
1
2013
490
0.080
Why?
Microdissection
1
2009
15
0.080
Why?
Pregnancy
3
2021
1191
0.080
Why?
Cell Transformation, Viral
1
2008
7
0.080
Why?
False Negative Reactions
2
2005
24
0.080
Why?
Sarcoma
2
1996
29
0.070
Why?
Hemorrhage
1
1990
265
0.070
Why?
Antigens, Tumor-Associated, Carbohydrate
1
2008
12
0.070
Why?
Peritoneal Cavity
1
1988
13
0.070
Why?
Molecular Chaperones
1
2008
49
0.070
Why?
Diagnosis, Differential
3
2019
371
0.070
Why?
Conization
1
2007
11
0.070
Why?
Electrocoagulation
1
2007
20
0.070
Why?
Electrosurgery
3
2012
15
0.070
Why?
Epithelial-Mesenchymal Transition
2
2018
115
0.070
Why?
Host-Pathogen Interactions
2
2020
91
0.070
Why?
Pathology, Surgical
1
2006
4
0.070
Why?
Sequence Analysis, DNA
2
2019
369
0.070
Why?
Case-Control Studies
2
2020
722
0.070
Why?
Image Processing, Computer-Assisted
1
2008
251
0.060
Why?
Automation
2
2021
19
0.060
Why?
Artifacts
2
2005
50
0.060
Why?
Area Under Curve
2
2017
95
0.060
Why?
Ovary
2
2019
69
0.060
Why?
Cell Transformation, Neoplastic
2
2012
120
0.060
Why?
Prevalence
2
2020
497
0.050
Why?
Mice, Nude
2
2017
331
0.050
Why?
Tumor Suppressor Protein p53
2
2022
103
0.050
Why?
Surveys and Questionnaires
3
2012
971
0.050
Why?
Epithelium
2
1997
39
0.050
Why?
Disease-Free Survival
2
2014
237
0.050
Why?
Referral and Consultation
2
2014
97
0.050
Why?
SEER Program
1
2022
47
0.050
Why?
Observer Variation
1
2002
43
0.050
Why?
ROC Curve
2
2013
144
0.050
Why?
Retinoblastoma Binding Proteins
1
2022
2
0.050
Why?
In Situ Hybridization
1
2022
34
0.050
Why?
Health Status Disparities
1
2022
65
0.050
Why?
Uterine Cervical Diseases
2
2012
6
0.050
Why?
Colonic Neoplasms
2
1997
121
0.050
Why?
Ubiquitin-Protein Ligases
1
2022
70
0.050
Why?
Incidence
1
2022
562
0.040
Why?
Vaccination
1
2022
186
0.040
Why?
Africa South of the Sahara
1
2020
13
0.040
Why?
APOBEC Deaminases
1
2020
1
0.040
Why?
Artificial Intelligence
1
2021
53
0.040
Why?
Antibodies, Monoclonal
2
2015
329
0.040
Why?
Aneuploidy
2
1997
21
0.040
Why?
Luteinization
1
2019
7
0.040
Why?
Costa Rica
1
2019
3
0.040
Why?
Costs and Cost Analysis
1
2019
40
0.040
Why?
Fatal Outcome
1
1999
67
0.040
Why?
Logistic Models
2
2012
407
0.040
Why?
Nucleic Acid Amplification Techniques
1
2019
7
0.040
Why?
Lymphatic Metastasis
1
1999
125
0.040
Why?
Molecular Sequence Data
3
2005
1051
0.040
Why?
Whole Genome Sequencing
1
2019
19
0.040
Why?
Global Health
1
2019
51
0.040
Why?
Practice Guidelines as Topic
1
2020
243
0.040
Why?
Databases, Genetic
1
2018
48
0.040
Why?
Organ Specificity
1
2018
82
0.040
Why?
Atypical Squamous Cells of the Cervix
1
2017
2
0.040
Why?
Receptors, Estrogen
1
2018
43
0.040
Why?
RNA, Long Noncoding
1
2018
32
0.040
Why?
Histocytochemistry
2
2015
20
0.040
Why?
Papillomavirus E7 Proteins
1
2017
8
0.040
Why?
Polymorphism, Genetic
1
2018
165
0.030
Why?
Simian virus 40
1
1977
8
0.030
Why?
Pyruvate Dehydrogenase Complex
1
2017
19
0.030
Why?
Oxidative Phosphorylation
1
2017
29
0.030
Why?
Chromosome Aberrations
1
1977
37
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2017
19
0.030
Why?
Nucleoside-Diphosphate Kinase
1
1997
2
0.030
Why?
Microarray Analysis
1
2017
64
0.030
Why?
Genomics
1
2018
123
0.030
Why?
Genes, p53
1
1997
14
0.030
Why?
Monomeric GTP-Binding Proteins
1
1997
16
0.030
Why?
Rectal Neoplasms
1
1997
9
0.030
Why?
Thyroid Nodule
1
1997
8
0.030
Why?
Genes, Tumor Suppressor
1
1997
39
0.030
Why?
Cyclooxygenase 2
1
2017
68
0.030
Why?
Evaluation Studies as Topic
1
1996
43
0.030
Why?
Intraoperative Period
1
1996
21
0.030
Why?
Gene Deletion
1
1997
119
0.030
Why?
Cisplatin
1
2017
179
0.030
Why?
Testicular Neoplasms
1
1996
16
0.030
Why?
Calcium
1
2017
235
0.030
Why?
Antibody Affinity
1
2015
13
0.030
Why?
Molecular Typing
1
2015
7
0.030
Why?
Gene Dosage
1
2015
35
0.030
Why?
Comparative Genomic Hybridization
1
2015
21
0.030
Why?
Double-Blind Method
1
2017
417
0.030
Why?
Discriminant Analysis
1
2015
16
0.030
Why?
Support Vector Machine
1
2015
21
0.030
Why?
Animals
5
2017
10415
0.030
Why?
Genomic Instability
1
2015
34
0.030
Why?
Survival Analysis
1
1996
288
0.030
Why?
Cluster Analysis
1
2015
125
0.030
Why?
Antibody Specificity
1
2015
114
0.030
Why?
Lung Neoplasms
1
1999
356
0.030
Why?
Laparoscopy
1
1997
146
0.030
Why?
Genetic Predisposition to Disease
1
2018
666
0.030
Why?
Indazoles
1
2014
18
0.030
Why?
DNA Helicases
1
2014
52
0.030
Why?
Chromosomes, Human, Pair 7
1
2013
12
0.030
Why?
Chromosomes, Human, Pair 20
1
2013
5
0.030
Why?
Chromosomes, Human, Pair 5
1
2013
10
0.030
Why?
Luminescent Measurements
1
2013
31
0.030
Why?
Chromosomes, Human, Pair 3
1
2013
17
0.030
Why?
Vaginal Diseases
2
1990
5
0.030
Why?
Platinum
1
2013
18
0.030
Why?
In Situ Hybridization, Fluorescence
1
2013
75
0.030
Why?
Cell Differentiation
1
1995
407
0.030
Why?
Contraceptives, Oral
1
2012
23
0.030
Why?
Parity
1
2012
49
0.020
Why?
Pilot Projects
1
2014
433
0.020
Why?
Genome-Wide Association Study
1
2013
234
0.020
Why?
Age Distribution
1
2012
73
0.020
Why?
Azacitidine
1
2011
8
0.020
Why?
Immunoenzyme Techniques
1
2011
67
0.020
Why?
Wnt Proteins
1
2011
34
0.020
Why?
Gene Silencing
1
2011
65
0.020
Why?
Antineoplastic Agents
1
2017
679
0.020
Why?
beta Catenin
1
2011
66
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2011
133
0.020
Why?
Down-Regulation
1
2011
199
0.020
Why?
Sexual Behavior
1
2012
91
0.020
Why?
Cell Cycle
1
2011
161
0.020
Why?
Severity of Illness Index
1
2012
452
0.020
Why?
Epigenesis, Genetic
1
2011
147
0.020
Why?
Promoter Regions, Genetic
1
2011
343
0.020
Why?
Blotting, Western
1
2011
514
0.020
Why?
Frozen Sections
1
2009
4
0.020
Why?
Cell Fusion
1
2008
7
0.020
Why?
Hemagglutinins, Viral
1
2008
3
0.020
Why?
Mandibular Neoplasms
1
1988
5
0.020
Why?
Frameshift Mutation
1
2008
14
0.020
Why?
Base Pairing
1
2008
25
0.020
Why?
Risk
1
2009
137
0.020
Why?
Keratinocytes
1
2008
33
0.020
Why?
Smoking
1
2012
473
0.020
Why?
Women
1
2008
12
0.020
Why?
Pelvic Inflammatory Disease
1
1988
1
0.020
Why?
Salpingitis
1
1988
1
0.020
Why?
Tissue Adhesions
1
1988
4
0.020
Why?
Ovarian Diseases
1
1988
7
0.020
Why?
Jurkat Cells
1
2008
30
0.020
Why?
Cell Proliferation
1
2011
806
0.020
Why?
Cardiac Tamponade
1
1988
8
0.020
Why?
Galactosyltransferases
1
2008
17
0.020
Why?
Pericarditis
1
1988
14
0.020
Why?
Candidiasis
1
1988
25
0.020
Why?
Cysts
1
1988
22
0.020
Why?
Postmenopause
1
2008
83
0.020
Why?
Parathyroid Hormone
1
1987
24
0.020
Why?
Vulvar Neoplasms
1
1987
25
0.020
Why?
Vagina
1
1987
42
0.020
Why?
Carcinoma, Hepatocellular
1
1988
131
0.020
Why?
Transfection
1
2008
318
0.020
Why?
Software
1
2008
125
0.020
Why?
Liver Neoplasms
1
1988
165
0.020
Why?
Cell Line
1
2008
696
0.020
Why?
Melanoma
1
2008
141
0.020
Why?
Models, Biological
1
2009
466
0.020
Why?
Colorectal Neoplasms
1
2008
138
0.020
Why?
Americas
1
2005
5
0.020
Why?
Asia
1
2005
20
0.020
Why?
Africa
1
2005
16
0.020
Why?
Aleutian Mink Disease Virus
1
2005
1
0.020
Why?
Gene Amplification
1
2005
22
0.020
Why?
Europe
1
2005
98
0.020
Why?
DNA Primers
1
2005
146
0.020
Why?
Base Sequence
1
2005
584
0.010
Why?
Mice
2
2011
4650
0.010
Why?
Rodent Diseases
1
1981
4
0.010
Why?
Gigantism
1
1981
1
0.010
Why?
Vaginal Neoplasms
1
1981
12
0.010
Why?
Neoplasms, Experimental
2
1981
58
0.010
Why?
Neoplasms, Germ Cell and Embryonal
1
1981
16
0.010
Why?
Lupus Erythematosus, Systemic
1
1988
991
0.010
Why?
Pancreatic Neoplasms
1
1987
540
0.010
Why?
Time Factors
1
1984
1591
0.010
Why?
Ploidies
1
1977
6
0.010
Why?
Clone Cells
1
1977
22
0.010
Why?
Karyotyping
1
1977
25
0.010
Why?
Transplantation, Homologous
1
1977
47
0.010
Why?
Antigens, Viral
1
1977
24
0.010
Why?
Neoplasm Transplantation
1
1977
90
0.010
Why?
NM23 Nucleoside Diphosphate Kinases
1
1997
2
0.010
Why?
Cricetinae
1
1977
129
0.010
Why?
Cell Division
1
1977
154
0.010
Why?
Microscopy, Electron
1
1996
94
0.010
Why?
Flow Cytometry
1
1996
288
0.010
Why?
Male
3
1997
13489
0.010
Why?
Nucleic Acid Hybridization
1
1990
76
0.010
Why?
RNA, Viral
1
1990
68
0.010
Why?
Hemochromatosis
1
1988
3
0.000
Why?
Spinal Neoplasms
1
1988
39
0.000
Why?
Pericardial Effusion
1
1988
12
0.000
Why?
Amphotericin B
1
1988
19
0.000
Why?
Immunochemistry
1
1987
2
0.000
Why?
Recurrence
1
1988
322
0.000
Why?
Staining and Labeling
1
1987
69
0.000
Why?
Thecoma
1
1981
1
0.000
Why?
Dysgerminoma
1
1981
2
0.000
Why?
Cystadenoma
1
1981
2
0.000
Why?
Mesothelioma
1
1981
4
0.000
Why?
Fibrosarcoma
1
1981
12
0.000
Why?
Hemangioma
1
1981
8
0.000
Why?
Mice, Inbred Strains
1
1981
61
0.000
Why?
Teratoma
1
1981
17
0.000
Why?
Zuna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (386)
Explore
_
Co-Authors (23)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_